What is the risk of alkali therapy for type 2 renal tubular acidosis (RTA)?

Updated: Dec 08, 2020
  • Author: Christie P Thomas, MBBS, FRCP, FASN, FAHA; Chief Editor: Vecihi Batuman, MD, FASN  more...
  • Print

Patients with type 2 RTA typically have hypokalemia and increased urinary K+ wasting. Administration of alkali in those patients leads to more HCO3- wasting and can worsen hypokalemia unless K+ is replaced simultaneously.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!